SLU-PP-332 is a synthetic research compound and peptide mimetic of exercise currently in early-stage research for its potential in treating metabolic disorders, such as obesity and Type 2 Diabetes.  Its potent action is rooted in its ability to bind to and activate ERR nuclear receptors (primarily ERR alpha), which triggers a genetic program in skeletal muscle identical to that induced by aerobic endurance exercise.